The EFGCP Geriatric Medicines Working Party is focused on developing three major areas of concerns regarding medicines for Europe's increasing elderly populations:

• A society concern: the present and future of healthcare for elderly populations
• A medical concern: the need for appropriately studied and labelled medicines, with particular attention on avoiding iatrogenic problems
• An ethical concern: ensuring appropriate healthcare and research protections for Europe's elderly populations

The goal of the Geriatric Medicines Working Party is to examine issues in the development of geriatric medicines that include approaches taken by ethics committees, information on medicines and medical research provided to elderly patients, informed consent in elderly populations, new regulatory approaches, specific pharmaceutical formulations, and strategic approaches to educating society.